El-Masry, T.A.; El-Nagar, M.M.F.; El Mahdy, N.A.; Alherz, F.A.; Taher, R.; Osman, E.Y.
RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527. Pharmaceuticals 2026, 19, 62.
https://doi.org/10.3390/ph19010062
AMA Style
El-Masry TA, El-Nagar MMF, El Mahdy NA, Alherz FA, Taher R, Osman EY.
RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527. Pharmaceuticals. 2026; 19(1):62.
https://doi.org/10.3390/ph19010062
Chicago/Turabian Style
El-Masry, Thanaa A., Maysa M. F. El-Nagar, Nageh A. El Mahdy, Fatemah A. Alherz, Reham Taher, and Enass Y. Osman.
2026. "RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527" Pharmaceuticals 19, no. 1: 62.
https://doi.org/10.3390/ph19010062
APA Style
El-Masry, T. A., El-Nagar, M. M. F., El Mahdy, N. A., Alherz, F. A., Taher, R., & Osman, E. Y.
(2026). RETRACTED: El-Masry et al. Potential Antitumor Activity of Combined Lycopene and Sorafenib Against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation. Pharmaceuticals 2024, 17, 527. Pharmaceuticals, 19(1), 62.
https://doi.org/10.3390/ph19010062
